算法在上升:一个机器学习驱动的前列腺癌文献调查
Simin Gu1, Jiajun Chen1, Chunyan Fan1
1Department of Urology, Qidong People's Hospital, Qidong Liver Cancer Institute, Affiliated Qidong Hospital of Nantong University, Qidong, Jiangsu, China.
Frontiers in oncology
|October 20, 2025
概括
机器学习 (ML) 显著推进前列腺癌 (PCa) 研究,深度学习和放射学领域迅速增长. 弥合ML算法和临床使用之间的差距需要合作和验证,以便更好地诊断和治疗PCa.
科学领域:
- * 应用到医学研究中的图书计量和科学计量.
- * 人工智能和机器学习在瘤学.
- * 前列腺癌诊断,预后和治疗计划.
背景情况:
- *机器学习 (ML) 在改善前列腺癌 (PCa) 诊断,预后和治疗方面非常有前途.
- *需要对全球研究趋势和PCa的ML应用知识结构进行全面的综合分析.
- *本研究系统地绘制了ML-PCa研究的演变,研究热点和协作格局.
研究的目的:
- *系统地绘制前列腺癌研究中ML应用的演变.
- * 确定该领域的关键研究热点和新兴前沿.
- *分析全球ML-PCa研究的协作格局.
主要方法:
- *对英语文章和评论进行系统的文献计量审查 (2005-2024年).
- *数据来源于科学网络和Scopus数据库.
- *使用CiteSpace,VOSviewer和R-bibliometrix分析出版趋势,国家/机构贡献,合作网络,作者生产力,期刊刊物以及关键词的共同出现.
主要成果:
- *确定了2,632个出版物,其中82%自2021年以来出版,呈指数级增长.
- *中国和美国在出版量方面处于领先地位;新兴的前沿领域包括深度学习,放射学和多式联络数据融合.
- * 国际合作显著,特定的机构和作者被确定为关键贡献者和中心.
结论:
- *在PCa研究中的ML应用正在迅速扩大,由深度学习和放射学驱动.
- * 在ML模型开发和临床实施之间仍然存在很大的差距.
- *未来的努力应优先考虑跨学科合作,多中心验证和监管调整,以将ML纳入临床工作流程.
更多相关视频
05:49Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
Published on: October 10, 2019
7.0K
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
17.1K
相关概念视频
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
